EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The enigma of sickle cell hepatopathy: Pathophysiology, clinical manifestations and therapy

Insia Rizvi iD, Divya Solipuram, Navneet Kaur, Aqsa Komel, Saba Batool, Jennifer Wang

British Journal of Haematology · 2026-02 · 208 (2) · 421-436

DOI: 10.1111/bjh.19620 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 08.07.2024. Verfasst von Insia Rizvi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Liver Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell disease (SCD) is one of the most common genetic disorders in the world predominantly affecting economically disadvantaged populations. There is a notable discrepancy between the growing adult SCD population and available diagnostic and therapeutic interventions for SCD. Sickle cell hepatopathy (SCH) is an all‐inclusive term to describe the acute and chronic liver manifestations of SCD. The pathophysiology of SCH follows no defined pattern or sequence that poses challenges to clinicians and researchers alike. Evidence is lacking for this underreported disease at various levels from diagnostic to therapeutic options. This paper reviews the basic pathophysiology, clinical features, biochemical and radiological findings of various SCH manifestations and outlines the management of each condition. Old and new therapy options in SCD including hydroxyurea, red blood cell exchange transfusion, ursodeoxycholic acid, voxelotor, l ‐glutamine and crizanlizumab have been reviewed to investigate the role of these options in treating SCH. The role of liver transplant, haematopoietic stem cell transplant and gene therapy in SCH patients have been reviewed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellLiver DiseasesHumansHydroxyureaHematopoietic Stem Cell TransplantationGenetic TherapyLiver TransplantationUrsodeoxycholic Acid

Stichwörter der Autor:innen

BMTclinical haematologygene therapyliver diseasesickle cell anaemiatransfusion medicine

Substanzen

HydroxyureaUrsodeoxycholic Acid

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Internal Medicine, Nassau University Medical Center, East Meadow, New York, USA.
  • Internal Medicine, North Alabama Medical Center, Florence, Alabama, USA.
  • Internal Medicine, Nishtar Medical College and Hospital, Multan, Punjab, Pakistan.
  • Internal Medicine, Carle Health Methodist Hospital, Peoria, Illinois, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.

ORCID-Profile: Insia Rizvi

Zitieren

APA

Rizvi, I., Solipuram, D., Kaur, N., Komel, A., Batool, S., & Wang, J. (2026). The enigma of sickle cell hepatopathy: Pathophysiology, clinical manifestations and therapy. British Journal of Haematology, 208(2), 421-436. https://doi.org/10.1111/bjh.19620

Vancouver

Rizvi I, Solipuram D, Kaur N, Komel A, Batool S, Wang J. The enigma of sickle cell hepatopathy: Pathophysiology, clinical manifestations and therapy. British Journal of Haematology. 2026;208(2):421-436. doi:10.1111/bjh.19620

BibTeX
@article{Rizvi2026,
  author = {Rizvi, Insia and Solipuram, Divya and Kaur, Navneet and Komel, Aqsa and Batool, Saba and Wang, Jennifer},
  title = {The enigma of sickle cell hepatopathy: Pathophysiology, clinical manifestations and therapy},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {208},
  number = {2},
  pages = {421--436},
  doi = {10.1111/bjh.19620}
}
Kostenlos starten →